⌘K
Loading ticker…
Voyager Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Voyager Therapeutics, Inc. Common Stock (VYGR) has a 3-month relative strength percentile of 22 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 47. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.3%, relative volume 4.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
22 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
VYGR is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -4.9% / -12.0%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
VYGR is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $6M notional. Top 3 carry $13M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $6M |
| IWMiShares Russell 2000 ETF | 0.01% | $5M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VYGR Jan avg: 9.06% median: -2.32% win: 25% σ: 30.97% n: 4 2022-04-12 → 2026-05-29 | VYGR Feb avg: -7.38% median: -9.41% win: 50% σ: 20.18% n: 4 2022-04-12 → 2026-05-29 | VYGR Mar avg: -0.93% median: 0.76% win: 50% σ: 13.18% n: 4 2022-04-12 → 2026-05-29 | VYGR Apr avg: -6.19% median: -5.97% win: 20% σ: 8.05% n: 5 2022-04-12 → 2026-05-29 | VYGR May avg: 5.58% median: 3.75% win: 60% σ: 31.64% n: 5 2022-04-12 → 2026-05-29 | VYGR Jun avg: 1.43% median: -0.97% win: 50% σ: 8.46% n: 4 2022-04-12 → 2026-05-29 (current) | VYGR Jul avg: 3.38% median: 7.97% win: 75% σ: 15.78% n: 4 2022-04-12 → 2026-05-29 | VYGR Aug avg: -6.67% median: -2.78% win: 50% σ: 16.78% n: 4 2022-04-12 → 2026-05-29 | VYGR Sep avg: 1.17% median: -5.83% win: 25% σ: 26.74% n: 4 2022-04-12 → 2026-05-29 | VYGR Oct avg: -2.74% median: -6.25% win: 25% σ: 14.59% n: 4 2022-04-12 → 2026-05-29 | VYGR Nov avg: 3.30% median: 5.47% win: 75% σ: 12.06% n: 4 2022-04-12 → 2026-05-29 | VYGR Dec avg: -0.58% median: -0.61% win: 50% σ: 13.98% n: 4 2022-04-12 → 2026-05-29 |